247 related articles for article (PubMed ID: 8689867)
1. The treatment of hormone refractory prostate cancer.
Panvichian R; Pienta KJ
Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
[No Abstract] [Full Text] [Related]
2. [What is safe in the therapy of advanced prostatic cancer?].
Gropp C; Burk K
Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
[No Abstract] [Full Text] [Related]
3. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
4. Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.
Ryan CJ; Zelefsky MJ; Heller G; Regan K; Leibel SA; Scher HI; Kelly WK
Urology; 2004 Jul; 64(1):90-4. PubMed ID: 15245942
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of estramustine phosphate and vinblastine in patients with hormone-refractory prostate cancer].
Awakura Y; Yamamoto M; Fukuzawa S; Itoh N; Nonomura M; Fukuyama T
Hinyokika Kiyo; 2000 Jul; 46(7):449-52. PubMed ID: 10965448
[TBL] [Abstract][Full Text] [Related]
6. Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
Arah IN; Dixon SC; Horti J; Figg WD
Neoplasma; 1999; 46(2):117-23. PubMed ID: 10466436
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management].
Wisard M; Gabellon S
Rev Med Suisse Romande; 1995 Mar; 115(3):241-7. PubMed ID: 7777765
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy for hormone-refractory prostate carcinoma: progress and pitfalls.
Syed S
Cancer; 2003 Nov; 98(10):2088-90. PubMed ID: 14601076
[No Abstract] [Full Text] [Related]
9. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul P
Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
[No Abstract] [Full Text] [Related]
10. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.
Mackler NJ; Dunn RL; Hellerstedt B; Cooney KA; Fardig J; Olson K; Pienta KJ; Smith DC
Cancer; 2006 Jun; 106(12):2617-23. PubMed ID: 16691618
[TBL] [Abstract][Full Text] [Related]
11. Combined castration and androgen blockade therapy in prostate cancer. Conclusions.
Denis L; Mettlin C
Cancer; 1990 Sep; 66(5 Suppl):1086-9. PubMed ID: 2203520
[No Abstract] [Full Text] [Related]
12. Prostate cancer--treatment of disseminated disease.
Abi-Aad AS; Opsomer RJ
Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
[No Abstract] [Full Text] [Related]
13. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
14. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
Matveev BP; Bukharkin BV
Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
[TBL] [Abstract][Full Text] [Related]
15. Controversies in chemotherapy of prostate cancer.
Heicappell R
Front Radiat Ther Oncol; 2002; 36():72-80. PubMed ID: 11842757
[No Abstract] [Full Text] [Related]
16. Chemotherapy of advanced cancer of the prostate.
Wirth MP
Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
[No Abstract] [Full Text] [Related]
17. A comparison of the treatment of metastatic prostate cancer by testicular ablation or total androgen blockade. The Canadian Anandron Study Group.
Cancer Treat Res; 1992; 59():29-40. PubMed ID: 1347692
[No Abstract] [Full Text] [Related]
18. Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancer.
Pienta KJ; Smith DC
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-72-S15-77. PubMed ID: 9346227
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
Pummer K; Lehnert M; Stettner H; Hubmer G
Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
[TBL] [Abstract][Full Text] [Related]
20. [Combination hormone-chemotherapy versus hormone therapy alone in the initial treatment of advanced prostate carcinoma--a prospective cooperative study].
Gorski J; Böhm WD; Illig HD; Koch R
Urologe A; 1988 Sep; 27(5):287-90. PubMed ID: 3051628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
